Stock screenerAll disclosures →
EDGAR →
MGX
Conviction 0HealthcareScan · Mon, Aug 10, 2026MGX$1.22-0.81%
ResistanceSupportVol 14Insider sell3
Vol MA14 129.52K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price1.22
Change-0.81%
Gap+0.81%
Rel volume0.42×
Avg volume140.83K
Avg $ vol173.93K
SMA 201.23
SMA 501.24
SMA 2001.53
Price vs 50-1.66%
Price vs 200-20.48%
MA stackbearish
50/200 cross—
Supertrenddown · 1.34
RSI (14)47
MACD hist0.00
MACD crossbull · 2d
Stoch %K / %D30 / 39
ADX (14)17
+DI / −DI21 / 13
RSI divergence—
MACD divergenceBullish
ATR %+3.59%
ADR %3.18%
52w high3.35
52w low1.14
From 52w high-63.58%
Above 52w low+7.02%
New 52w highNo
SqueezeOn · 2d
Bollinger width9.49%
%B0.43
Donchian pos19.44%
Donchian high1.37
Donchian low1.19
AVWAP (52w high)1.88
vs AVWAP high-35.04%
AVWAP (52w low)1.24
vs AVWAP low-1.75%
OBV trendFlat
Chaikin MF (20)-0.26
Today vs 20d0.42×
Avg vol (14d)129.52K
Avg vol (20d)140.83K
Avg $ vol (20d)173.93K
Market cap46.09M
RS 3m (vs SPY)-19.08%
RS 6m (vs SPY)-26.88%
RS line new highNo
Trend template0/8
Technical rank19.4
1 week+0.83%
1 month-3.94%
3 months-13.48%
6 months-20.78%
1 year-36.46%
YTD-26.95%
P/E-0.52
P/B0.41
P/S1.83
P/FCF-0.52
EPS-2.36
Div yield—
ROE-78.06%
ROA-50.59%
Debt/Eq—
Current4.50
EV/EBITDA—
Gross margin—
Net margin-348.54%
Rev growth-51.79%
EPS growth-12.57%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value7.06M
Revenue1.25M
Net income-27.48M
Gross profit—
Free cash flow-89.47M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out37.65M
Employees118
ListedFri, Feb 9, 2024
Free float22.51M
Float %60.0%
Short interest1.54M
Days to cover6.5d
Short volume48.4%
Squeeze score44 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank19.4 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.36
Support1.13
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in MGX
No recent disclosed trades by Congress in MGX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in MGX · 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Irish Jian See Remarks · Common Stock · 2026-06-05 | Other | — | — | 2026-06-05 | 2026-06-10 |
Wapnick Pamela Chief Financial Officer · Common Stock · 2026-06-05 | Sell | 2.88K | $4K | 2026-06-05 | 2026-06-10 |
Irish Jian See Remarks · Common Stock · 2026-06-05 | Sell | 3.74K | $5K | 2026-06-05 | 2026-06-10 |
Irish Jian See Remarks · Common stock · 2026-06-05 | Other | — | — | 2026-06-05 | 2026-06-10 |
Wein Matthew See Remarks · Common Stock · 2026-06-05 | Sell | 558 | $725 | 2026-06-05 | 2026-06-10 |
SEC filings
EDGAR filings in MGX · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.